Shineco, Inc. (SISI)
| Market Cap | 216.64K -96.3% |
| Revenue (ttm) | 9.60M +1,133.3% |
| Net Income | -38.90M |
| EPS | -422.46 |
| Shares Out | 900.61K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 183 |
| Average Volume | 2,142 |
| Open | 0.2406 |
| Previous Close | 0.1666 |
| Day's Range | 0.2406 - 0.2406 |
| 52-Week Range | 0.0039 - 54.9950 |
| Beta | -2.23 |
| RSI | 46.77 |
| Earnings Date | May 18, 2026 |
About Shineco
Shineco, Inc., through its subsidiaries, plants, processes, and distributes agricultural produce. The company also engages in the development, production, and distribution of diagnostic products and related medical devices; trading of fresh fruits; and processing, producing, and distribution of silk and silk fabrics, as well as other by-products. In addition, it operates a restaurant in Fuzhou. The company was formerly known as Beijing Tenet Jove Technological Development Co., Ltd. Shineco, Inc. was incorporated in 1997 and is based in Beijing,... [Read more]
Financial Performance
In fiscal year 2024, Shineco's revenue was $9.80 million, an increase of 1680.61% compared to the previous year's $550,476. Losses were -$22.45 million, 68.0% more than in 2023.
Financial StatementsNews
Shineco signs $8.7M tech services contract, announces BICC collaboration
Shineco (SISI) subsidiary, Xi’an Dong’ao Health Management has signed a technology services contract valued at $8.7M with Xinke Future Biotechnology for the research and development of “microalgae-der...
Shineco (SISI) Ignites Growth: $8.7M Tech Deal & Major Singapore Alliance Unleash Dual Engines
BEIJING , Sept. 12, 2025 /PRNewswire/ -- Shineco Inc. (NASDAQ: SISI) ("Shineco" or the "Company"), a developer and commercializer of induced pluripotent stem cell (iPSC) technology platforms, today an...
Shineco unit achieves mass production of high-purity soybean phospholipids
Shineco (SISI) announced that its subsidiary, Fuzhou Meidashan Biotechnology Co., Ltd., has successfully achieved large-scale production of high-purity, highly active free-form soybean phospholipids. ...
Shineco Achieves Mass Production of High-Purity Physical Phospholipids, Breaking Foreign Monopoly and Unlocking Innovation Across Industries
BEIJING , Sept. 10, 2025 /PRNewswire/ -- Shineco Inc. (NASDAQ: SISI) ("Shineco" or the "Company"), a leading developer of induced pluripotent stem cell (iPSC) technology platforms, today announced tha...
Shineco enters strategic cooperation agreement with BICC
Shineco (SISI) has entered into a strategic cooperation agreement with Singapore-based BICC to jointly promote the implementation and redemption of “on-chain cell assets” across multiple institutions ...
Shineco (NASDAQ: SISI) & BICC: From "Tech On-Chain" to "Global Redeemability"--RWA Ecosystem Takes Off for Long-Term Growth
BEIJING , Aug. 27, 2025 /PRNewswire/ -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, has entered into a strateg...
Shineco Stock (SISI) Rockets 45% on Cellular Blockchain Agreement
Shineco stock rallied on Wednesday after the company announced a cellular blockchain agreement.
Shineco, Plus Me execute cooperation agreement
Shineco (SISI) announced the execution of a “Cellular Asset On-Chaining and Marketing Ecosystem Cooperation Agreement” with blockchain infrastructure provider Plus Me Limited. This partnership enables...
Shineco Unveils World's First On-Chain Cell Asset Tokenization Platform; Strategic Acquisition Expands Global Blockchain-Biotech Network
BEIJING , Aug. 20, 2025 /PRNewswire/ -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a leading innovator in induced pluripotent stem cell (iPSC) technology, today announced the execution o...
Shineco Establishes Biological Cell Digital Division to Integrate Biological Cell Assets and Blockchain Technology
BEIJING , Aug. 13, 2025 /PRNewswire/ -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a manufacturer of induced pluripotent stem cell (iPSC) technology platforms, today announced the establ...
Shineco Inc trading halted, news pending
19:50 EDT Shineco (SISI) Inc trading halted, news pending
Shineco to effect 50-for-1 reverse stock split
Shineco’s (SISI) Board of Directors has approved a 50:1 reverse stock split of the Company’s issued and outstanding common stock, par value $0.001 per share to be effective 12:01 a.m.,…
Shineco, Inc. to Effect 50:1 Reverse Stock Split
Measure taken to Comply with Nasdaq Rule 5550(a)(2) Regarding Minimum Bid Price BEIJING, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. (Nasdaq:SISI) ("Shineco" or the "Company"), a provider of innov...
Shineco executives launch up to $2M open-market stock purchase program
Shineco (SISI) announced that Ms. Jennifer Zhan, the CEO, and Mr. Sam Wang, the Company’s CFO, will jointly initiate a stock purchase program to purchase up to $2,000,000 of the…
Shineco subsidiary partners with Total World Marketing
Shineco (SISI) announced that InfiniClone, Shineco’s majority-owned subsidiary in which the Company acquired a 51% equity interest on April 25, 2025, has officially launched its Southeast Asian market...
Shineco subsidiary to acquire 51% equity interest in InfiniClone
Shineco (SISI) announced that on April 22, 2025, its subsidiary, Shineco Life Sciences Group Hong Kong, entered into a Share Purchase Agreement with Dr. Lim Kah Meng to acquire 51%…
Shineco announces acquisition of medical device company
Shineco (SISI) announced that on March 20, 2025, Shineco Life Science Group Hong Kong Co., a subsidiary of the Company, entered into a Stock Purchase Agreement with Yi Yang, for…
Shineco Announces Acquisition of Medical Device Company
The Acquisition is Expected to Create Immediate Synergies with the Company's Existing Medical Device Business BEIJING, March 25, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NA...
Shineco files to sell 15M shares of common stock for holders
16:36 EST Shineco (SISI) files to sell 15M shares of common stock for holders
Shineco files to sell 15M shares of common stock for holders
16:11 EST Shineco (SISI) files to sell 15M shares of common stock for holders
Shineco announces 1-for-24 reverse stock split
Shineco (SISI) announced that effective at 12:01 a.m., EDT, on November 12, 2024, the Company will effect a one-for-twenty four reverse stock split of its outstanding common stock. The Reverse…
Shineco Inc trading halted, news pending
19:50 EST Shineco (SISI) Inc trading halted, news pending
Future FinTech Announces the Appointment of Hu Li as the New CEO
NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Future Fintech Group Inc. (NASDAQ: FTFT), (hereinafter referred to as "Future FinTech", "FTFT" or the "Company"), a comprehensive financial and digital technolo...
Shineco Announces Closing of $2 Million Underwritten Public Offering
Beijing, July 15, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced ...
Shineco prices 1.87M shares at $1.07 in underwritten public offering
Shineco announced the pricing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate…